FSD Pharma Inc's (CSE:HUGE) (NASDAQ:HUGE) Dr Ed Brennan sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Dr Brennan spoke about the company's recent achievement, and how it plans to double down on its biosciences division.
FSD Pharma explains how its 'doubling down' on biosciences division
Quick facts: FSD Pharma
Price: 9.8 CAD
Market Cap: $76.6 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE